Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions 2024-08-19 21:00
CARsgen Announces Enrollment Completion in China GC/GEJ Pivotal Phase II Clinical Trial of the First-in-class Claudin18.2 CAR T (Satri-cel) 2024-08-19 20:50
Health In Tech Partners with NovaNet and Tall Tree to Host Webinar on the Latest Strategies for Personalizing Client Health Coverage 2024-08-19 20:30
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 2024-08-19 20:00
2024 World Life Science Conference Scheduled for October 19 in Hainan, China 2024-08-18 20:20
De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts 2024-08-16 18:00
Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform is Officially Launched 2024-08-16 06:00
Vimgreen Completes Enrollment of Its Phase 2 Clinical Trial Evaluating VG081821AC for the Treatment of Parkinson's Disease 2024-08-15 21:37
Zepp Health Partners with Wild.AI to Offer Groundbreaking Women's Wellness App on Amazfit Smartwatches 2024-08-15 21:00
Xinhua Silk Road: Italy-based Salov, subsidiary of China's Bright Food Group, promotes olive oil culture through talent dev't programs 2024-08-15 15:54
Ivonescimab (PD-1/VEGF) Received Priority Review from China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC 2024-08-15 07:30
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" 2024-08-13 20:00
Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program 2024-08-13 07:46
Momcozy's Ongoing Campaign for Breastfeeding Awareness Month Connects Moms and Breaks Barriers 2024-08-12 22:00
Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Granted Breakthrough Therapy Designation by China's NMPA 2024-08-12 22:00
Xiao-I Corporation Showcases Hearview Smart Glasses at Successful U.S. Launch Event 2024-08-12 21:30
VISEN Pharmaceuticals announced that the Phase 3 PaTHway China Trial of Palopegteriparatide achieved primary and key secondary endpoints in the treatment of adults with hypoparathyroidism 2024-08-12 21:00
Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial 2024-08-12 20:30
Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China 2024-08-12 13:55
IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Two New Autoimmune Disease Indications 2024-08-12 13:52
1 26 27 28 29 30 808